查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1336716

全球医用电极市场 - 2023-2030

Global Medical Electrodes Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球医疗电极市场将于 2022 年达到 9 亿美元，预计到 2030 年将达到 12 亿美元，2023-2030 年预测期间年复合成长率为 4.1%。

医用电极能够对内部离子电流进行表面测量，从而对几种神经、肌肉、眼科、心臟和其他疾病进行非侵入性诊断，这些疾病通常需要手术干预来确认其存在。电极通常使用简单、一次性（或易于消毒），并且在其所协助的活动中通常是独特的。电极的主要功能是保持患者和用于测量或记录活动的仪器之间的最佳电接触。

此外，全球医疗电极市场受到多种因素的推动，例如心血管和神经系统疾病的增加、技术进步、微创手术的增加、医疗保健支出的增加以及对早期疾病检测和管理的认识不断提高。

市场动态

心血管疾病患病率上升

心血管疾病患病率的上升是推动医疗电极市场在预测期内增长的重要关键因素之一，因为与此类疾病相关的高死亡率风险增加了患者频繁医疗诊断的比率。例如，根据美国疾病控制与预防中心更新的情况说明书，每 40 秒就有 805,000 人经历一次心脏病发作，其中 605,000 人是首次心脏病发作，200,000 人是已经经历过心脏病的人。大约五分之一的心脏病发作是无声的，在患者不知情的情况下造成损害。

技术进步的崛起

医用电极通常用于心电图 (ECG) 监测系统来诊断心臟问题。心电图是最广泛使用的心血管疾病诊断方法，并且测试技术正在不断改进以满足当今的技术需求。与标准的心臟动态心电图和事件记录仪相比，这种革命性的技术设备更具成本效益且用户友好。

此外，随着电极的小型化和电极电缆的消除，设备现在可以安装在患者的胸部，而无需缠结电线。在分析期间，医疗设备的此类技术发展极大地促进了市场增长。

例如，2022 年 10 月 5 日，卡内基梅隆大学的研究人员开发了 CMU 阵列——一种用于脑机接口平台的微电极阵列。该解决方案有望改变医生治疗各种神经疾病的方式。此类创新将促进医疗电极市场的采用。

严格的政府法规

严格的政府法规是预测期内阻碍市场增长的限制因素之一。严格的政府法规在医疗电极市场中至关重要，因为它们确保了产品的安全、质量和功效。这些法规有助于维持高标准、促进创新和保护患者福祉。遵守这些要求对于製造商来说至关重要，有助于确保医用电极的整体可靠性。

此外，在一些新兴或不发达国家，缺乏对此类设备的相关技术突破和优势的了解可能会阻碍该市场在预测期内的增长。

目录

第 1 章：方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 按类型分類的片段
  • 按应用程序片段
  • 最终用户的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 心血管疾病患病率上升
      • 技术进步的崛起
    • 限制
      • 严格的政府法规
    • 机会
      • 微创手术日益受到关注
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情况
    • Covid-19 后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章：按产品类型

  • 诊断医用电极
  • 治疗医用电极

第 8 章：按类型

  • 湿电极
  • 干电极
  • 针电极

第 9 章：按申请

  • 心脏病学
  • 神经生理学
  • 睡眠障碍
  • 术中监测
  • 其他的

第 10 章：最终用户

  • 医院
  • 诊断中心
  • 其他的

第 11 章：按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Medtronic
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Koninklijke Philips NV
  • Ambu
  • Natus Medical Incorporated
  • 3M
  • CONMED Corporation
  • Rhythmlink International, LLC
  • Leonhard Lang GmbH
  • Nihon Kohden Corporation
  • Compumedics

第 14 章：附录

简介目录
Product Code: MD1621

Market Overview

Global Medical Electrodes Market reached US$ 0.9 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 4.1% during the forecast period 2023-2030.

Medical electrodes enable the surface measurement of internal ionic currents, resulting in a non-invasive diagnostic for several neurological, muscular, ophthalmic, cardiac, and other illnesses that would normally require surgical intervention to confirm their presence. The electrodes are often simple to use, disposable (or readily sterilizable), and often distinctive in the activities they assist with. The electrode's primary function is to maintain optimal electrical contact between the patient and the instrument used to measure or record activity.

Furthermore, the global medical electrodes market is driven by various factors like rising cardiovascular and neurological diseases, technological advancements, a rise in minimally invasive surgeries, increasing healthcare spending, and rising awareness about early disease detection and management.

Market Dynamics

Rise in the Prevalence of Cardiovascular Diseases

The rise in the prevalence of cardiovascular diseases is one of the significant key factors that helps the medical electrodes market to grow during the forecast period, owing to the high mortality risk associated with such disorders has increased the rate of frequent medical diagnosis of patients. For instance, according to the Centers for Disease Control and Prevention updated factsheet in the US, 805,000 people experience a heart attack every 40 seconds, with 605,000 being first-time cases and 200,000 being those who have already experienced one. About 1 in 5 heart attacks are silent, causing damage without the person being aware.

Rise in Technological Advancements

Medical electrodes are often used in electrocardiogram (ECG) monitoring systems to diagnose heart problems. ECG has been the most widely utilised type of diagnostics for cardiovascular diseases, and testing techniques are improving to match today's technological needs. The revolutionary technology-incorporated devices, as opposed to standard cardiac holter and event recorders, are far more cost-effective and user-friendly.

Furthermore, with the miniaturisation of electrodes and the elimination of electrode cables, devices may now be installed on the patient's chest without a tangle of wires. During the analysis period, such technical developments in medical devices considerably enhanced market growth.

For instance, on 5th October 2022, researchers at Carnegie Mellon University developed the CMU Array - a microelectrode array for brain-computer interface platforms. The solution is expected to transform the way doctors treat various neurological ailments. Such innovations will bolster the medical electrodes market adoption.

Stringent Government Regulations

Stringent government regulations are one of the restraints that hamper market growth during the forecast period. As stringent government regulations are critical in the medical electrodes market because they ensure product safety, quality, and efficacy. These regulations aid in the maintenance of high standards, the promotion of innovation, and the protection of patient well-being. Compliance with such requirements is critical for manufacturers and helps to ensure the overall reliability of medical electrodes.

Furthermore, a lack of knowledge about the associated technical breakthroughs and advantages of such devices in some emerging or underdeveloped countries may impede the growth of this market during the forecast period.

Segment Analysis

The global medical electrodes market is segmented based on product type, type, application, end-user and region.

The Diagnostic Medical Electrodes From the Product Segment Accounted for Approximately 41.7% of the Medical Electrodes Share

The diagnostic medical electrodes from the product segment with around 41.7% is expected to dominate during the forecast period owing to recent launches by key players, technological advancements will drive the segment growth. For instance, in November 2022, Brain Scientific a Florida-based medical device technology company, announced the immediate release of the improved and updated NeuroCap device and the signing of a distribution partnership with D&D Medical, Inc., to sell the company's neurology devices in Tennessee, Kentucky, Indiana, and West Virginia.

Brain Scientific developed the NeuroCap to streamline EEG prep, testing and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, due to its superior healthcare infrastructure, new launches, effective government policies, vast multinational company base, and a high level of awareness about testing and testing devices in healthcare. This region also witnesses a high prevalence of chronic inflammatory disorders, such as cardiovascular diseases, diabetes, inflammatory bowel disease (IBD), and cancer, compared to other chronic indications.

Increasing expenditure on healthcare and rising awareness among people, advancement of technologies for treatment, and increase in biopharmaceutical establishment across the region are also contributing to the growth of medical electrodes share of this region.

For instance, in May 2023 NeuroOne Medical Technologies Corporation, a medtech company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced the commercial launch of the Evo sEEG electrode product line in the United States.

Competitive Landscape

The major global players in the medical electrodes market include Medtronic, Koninklijke Philips N.V., Ambu, Natus Medical Incorporated, 3M, CONMED Corporation, Rhythmlink International, LLC, Leonhard Lang GmbH, Nihon Kohden Corporation, Compumedics and among others

COVID-19 Impact Analysis

Segmentation

By Product Type

  • Diagnostic Medical Electrodes

Electrocardiography

Electroencephalogram

Electromyography

  • Therapeutic Medical Electrodes

Defibrillator

Transcutaneous Electrical Nerve Stimulation electrodes

Electrosurgical Electrodes

Neuromuscular and Muscular Electrical Stimulation (NMES)

Pacemaker electrodes

By Type

  • Wet Electrodes
  • Dry Electrodes
  • Needle Electrodes

By Application

  • Cardiac
  • Neurophysiology
  • Sleep Disorders
  • Intraoperative Monitoring
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Others

By Region

  • North America

U.S.

Canada

Mexico

  • Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

  • South America

Brazil

Argentina

Rest of South America

  • Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

  • Middle East and Africa

Key Developments

  • In December 2022 NeuroOne Medical Technologies Corporation fulfilled a commercial order for sEEG electrodes and shipped them to Zimmer Biomet, as per their agreement. This development marks a significant milestone for the company and its efforts to expand its market presence.
  • In November 2022, EMOTIV Partnered with X-trodes to launched New Medical-Grade, At-Home Solution for Brain Monitoring Research. X-trodes' wearable sensing technology is partnered with EmotivPRO, a neuroscience data platform, to enhance sleep studies and kinesiology research. The proprietary dry-printed electrodes stream user-generated data through the EmotivPRO mobile app, allowing processing and analysis on the cloud-based platform.
  • In October 2022 Nihon Kohden launched a new product called the Smart Cable NMT Pod and disposable electrode. This device allows clinicians to objectively monitor the depth of paralysis in patients during surgery when a neuromuscular blockade agent (NMBA) is administered, whether non-depolarizing or depolarizing. With this innovation, clinicians can confidently monitor neuromuscular blockade, improving patient outcomes and enhancing surgical procedures.

Why Purchase the Report?

  • To visualize the global medical electrodes market segmentation based on product type, type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of medical electrodes market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global medical electrodes report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Cardiovascular Diseases
      • 4.1.1.2. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Government Regulations
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Focus toward Minimally Invasive Surgeries
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Diagnostic Medical Electrodes *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Therapeutic Medical Electrodes

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Wet Electrodes *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Dry Electrodes
  • 8.4. Needle Electrodes

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Application
    • 9.1.2. Market Attractiveness Index, By Product Application
  • 9.2. Cardiology *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Neurophysiology
  • 9.4. Sleep Disorders
  • 9.5. Intraoperative Monitoring
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Koninklijke Philips N.V.
  • 13.3. Ambu
  • 13.4. Natus Medical Incorporated
  • 13.5. 3M
  • 13.6. CONMED Corporation
  • 13.7. Rhythmlink International, LLC
  • 13.8. Leonhard Lang GmbH
  • 13.9. Nihon Kohden Corporation
  • 13.10. Compumedics

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us